• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
ZEISS INTRABEAM 700

ZEISS Gains FDA Approval for INTRABEAM 700, Advancing Intraoperative Radiotherapy Solutions

As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT).

Read more →
VAS-101 in TopiClick dispenser.

In the United States, Vascarta commences Phase 1 clinical study of VAS-101 for sickle cell disease as part of the Proof of Concept

A first in human proof of concept phase I clinical study of VAS-101 (Vasceptor®; topical curcumin gel) in sickle cell disease (SCD) is underway. The study is being conducted by the Foundation for Sickle Cell Disease Research (FSCDR) in Hollywood, Florida, under the supervision of the principal investigator, Dr. Gershwin Blyden.

Read more →
RS001 Cardio-respiratory

Respiree secures Singapore HSA clearance for its pediatric expansion of the cardio-respiratory wearable and its new EHR streamlined platform

AI/ML health tech startup Respiree has received clearance from the Health Sciences Authority (HSA) to extend its RS001 cardio-respiratory wearable to pediatric populations. This clearance also enables the extension of Respiree's software platform, introducing enterprise-grade pathway management services and EHR interoperability which further enhances its innovative healthcare solutions.

Read more →